AUXILIUM PHARMACEUTICALS INC's ticker is AUXL and the CUSIP is 05334D107. A total of 1 filers reported holding AUXILIUM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36 | 0.0% | 1 | 0.0% | 0.00% | – |
| Q2 2023 | $36 | 0.0% | 1 | 0.0% | 0.00% | – |
| Q1 2023 | $36 | 0.0% | 1 | 0.0% | 0.00% | – |
| Q4 2022 | $36 | – | 1 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 9,684,062 | $263,212,000 | 10.88% |
| Tamarack Capital Management, LLC | 925,000 | $25,142,000 | 6.28% |
| Healthcare Value Capital, LLC | 300,000 | $8,154,000 | 5.33% |
| Healthcare Value Capital, LLC | 179,481 | $4,878,000 | 3.19% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,566,705 | $69,763,000 | 2.85% |
| KING INVESTMENT ADVISORS INC/TX | 215,800 | $5,865,000 | 2.69% |
| TAMRO Capital Partners LLC | 1,983,557 | $53,913,000 | 2.35% |
| SECTOR GAMMA AS | 284,020 | $7,720,000 | 1.85% |
| Elk Creek Partners, LLC | 138,222 | $3,757,000 | 1.62% |
| Artal Group S.A. | 1,375,000 | $37,373,000 | 1.35% |